| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -36,216 | -26,160 |
| Stock-based compensation | 5,389 | 3,611 |
| Depreciation | 2,782 | 1,865 |
| Non-cash operating lease expense | 374 | 241 |
| Loss on disposal of fixed assets | -47 | - |
| Non-cash license revenue | 1,000 | - |
| Net amortization of investments | 167 | 1 |
| Gain on lease modification | 105 | - |
| Impairment loss of fixed assets | 0 | - |
| Prepaid expenses and other current assets | -1,638 | -2,020 |
| Other assets | -91 | -32 |
| Deferred revenue | - | 0 |
| Accounts payable | -1,257 | -1,944 |
| Accrued expenses and other current liabilities | -2,324 | -1,637 |
| Non-current operating lease liabilities | -644 | -490 |
| Net cash used in operating activities | -31,392 | -22,463 |
| Maturities of investments | 15,600 | 15,600 |
| Purchases of investments | 43,416 | 0 |
| Purchase of property and equipment | 71 | 0 |
| Net cash used in by investing activities | -27,887 | 15,600 |
| Proceeds from sale of common stock, pre-funded warrants and common stock warrants, net of offering costs | 44,480 | 0 |
| Proceeds from the exercises of stock options and purchases pursuant to employee stock purchase plan | 25 | 8 |
| Taxes paid related to net share settlement of equity awards | 65 | 65 |
| Net cash provided by financing activities | 44,440 | -57 |
| Net decrease in cash and cash equivalents | -14,839 | -6,920 |
| Cash and cash equivalents at beginning of period | 57,387 | - |
| Cash and cash equivalents at end of period | 42,548 | - |
Shattuck Labs, Inc. (STTK)
Shattuck Labs, Inc. (STTK)